Vion (formerly Oncorx) interesting play on Gene Therapy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pierre Borczuk who wrote (59)	8/22/1997 9:47:00 PM
From: Harry Stover	of 370

Hello, I have read that Vion has amended their agreement with Yale in that Vion will issue stock to Yale instead of milestone payments. I also observed in their cash available is about 8.4 million. It sounds like money might be getting tight. Vion may issues more shares to the public to raise some cash. So for the above reasons I have sold some of my shares in Vion. I still own some shares and I still like the company, but I will try to repurchase shares at a lower price. Best to you, Harry Email "pidipady@juno.com"

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next